|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/436 | (2006.01) |
| A61K 9/1623 | (2013.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61K 9/14 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 9/16 | (2006.01) | ||
| A61K 9/0078 | (2013.01) | ||
| A61K 31/445 | (2013.01) | ||
| A61K 9/145 | (2013.01) | ||
| A61K 31/436 | (2013.01) | ||
| A61K 9/14 | (2013.01) | ||
| A61K 47/26 | (2013.01) |
| (11) | Number of the document | 3738592 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20183293.8 |
| Date of filing the European patent application | 2014-10-07 | |
| (97) | Date of publication of the European application | 2020-11-18 |
| (45) | Date of publication and mention of the grant of the patent | 2022-01-26 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201361888066 P | 2013-10-08 | US |
| (72) |
ROTHBERG, Jonathan, M. , US
LICHENSTEIN, Henri , US
ARMER, Thomas , US
MELVIN, Jr Lawrence S. , US
|
| (73) |
AI Therapeutics, Inc. ,
530 Old Whitfield Street, Guilford, CT 06437,
US
|
| (54) | RAPAMYCIN FOR THE TREATMENT OF LYMPHANGIOLEIOMYOMATOSIS |
| RAPAMYCIN FOR THE TREATMENT OF LYMPHANGIOLEIOMYOMATOSIS |